Although virtually no one in the urban bubble where biopharmaceutical companies reside expected it to happen, Donald Trump won. So, now what?
Shire Inc. recently launched Xiidra, the first medicine indicated for the signs and symptoms of dry eye disease and the company’s first ophthalmic drug.
Special Feature: Pharma Leaders of Innovation
Advisory Panels, Antibiotics, August 2016, Big Pharma, Blood Thinner, Brands, Cloud, Diabetes, DTC, Epilepsy, FDA, FDA/Regulatory, Foundations, Gender diversity, Generics, Healthcare Communications Agencies, Healthcare Communications Networks, Healthcare Practitioners, Innovation, Mental Health, Neuroscience, Opioids, Pharma, Pharma Leaders of Innovation special feature, Product Launches, Sales & Marketing, Schizophrenia, Specialty Pharma, TechnologyMed Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.
There is no place more social than Cannes. (Just spend an evening at The Gutter Bar.) And, yet, when it comes to creative ideas using social media, social didn’t really show up on the pharma shortlist this year.
Delivering Clients the Lion’s Share of What They Deserve: 3 Reasons Winning a Cannes Lion Should Be Clients’ New Success Metric
American Medical Association (AMA), August 2016, Black Box Warning, Cannes/Lions Health, DTC, Health Outcomes, Healthcare Communications Agencies, Marketing & Advertising, Pharma, Pharmacists, TelevisionIt’s tough times on Medicine Avenue. But, by aiming to achieve one simple, straightforward metric, I’d argue we could turn every one of those challenges around. That metric is winning a Cannes Lion.
To build brands in this most personal of industries, healthcare marketers must first make the human connection.
At the end of June 2016, Omnicom Health Group announced the launch of DDB Health. The new organization combines the former AgencyRx, Flashpoint Medica, Synergy, and DDB Health Germany and DDB Health Paris into a single organization.
Pharma brands are still spending furiously on DTC – something like a billion dollars more in 2015 than in 2014, with more growth expected this year – and patients are still demanding and sharing more information about drugs and medical conditions, with or without approval from their doctors.
A listing of the total DTC expenditure for prescription medicines in 2011, 2012, 2013, 2014 and 2015